\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ reveals\\ a\\ hard\\ subcutaneous\\ mass\\ located\\ in\\ the\\ right\\ breast\\ at\\ 1200\\;\\ approximately\\ 5cm\\ from\\ the\\ nipple\\.\ \(0\)\
\-\ treatment\\ is\\ currently\\ pending\\ along\\ with\\ estrogen\\/progesterone\\ receptor\\ assays\\ and\\ her\\-2\\/neu\\ studies\\.\ \(0\)\
\-\ mammogram\\:\\ \\ spiculated\\,\\ ill\\-defined\\ density\\,\\ located\\ midline\\ craniocaudal\\ view\\ and\\ superior\\ to\\ nipple\\ in\\ mediolateral\\ view\\.\\ \\ birads\\ v\\.\\ \\ the\\ images\\ were\\ compared\\ with\\ prior\\ studies\\ from\\ 2001\\ and\\ 2002\\ showing\\ a\\ density\\ increased\\ in\\ size\\ and\\ irregularity\\.\\ \\ past\\ workup\\ of\\ following\\ the\\ 2002\\ mammogram\\ included\\ spot\\ compression\\ vies\\ and\\ ultrasound\\;\\ however\\,\\ had\\ the\\ 2001\\ films\\ been\\ present\\ at\\ that\\ time\\,\\ biopsy\\ of\\ the\\ new\\ assymetric\\ density\\ would\\ have\\ been\\ more\\ appropriate\\.\ \(0\)\
\-\ ultrasound\\ exam\\ of\\ this\\ region\\ demonstrates\\ a\\ 2\\.8\\ cm\\ heterogeneously\\ hypoechoic\\ mass\\ with\\ irregular\\ margins\\ and\\ posterior\\ acoustic\\ shadowing\\.\ \(0\)\
\-\ invasive\\ ductal\\ carcinoma\ \(7\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\ \(0\)\
\-\ 1\\.\\	invasive\\ ductal\\ carcinoma\ \(0\)\
\-\ 2\\.\\	invasive\\ lobular\\ carcinoma\ \(0\)\
\-\ 3\\.\\	phylloides\\ tumor\ \(0\)\
\-\ 4\\.\\	metastasis\ \(0\)\
\-\ 5\\.\\	benign\\ fibrocystic\\ change\ \(0\)\
\-\ history\\:\\ \\ a\\ 56\\ year\\ old\\ post\\ menopausal\\ female\\ presents\\ to\\ mgmc\\ mammography\\ with\\ the\\ complaint\\ of\\ a\\ palpable\\ breast\\ mass\\ in\\ her\\ right\\ breast\\.\\ \\ the\\ mass\\ has\\ been\\ palpable\\ by\\ the\\ patient\\ for\\ 3\\-4\\ weeks\\.\ \(0\)\
\-\ last\\ mammogram\\:\\ 29\\ august\\ 2002\\.\\ \\ patient\\ underwent\\ spot\\ compression\\ views\\ for\\ an\\ asymmetric\\ density\\ as\\ well\\ as\\ ultrasound\\ at\\ that\\ time\\;\\ no\\ evidence\\ of\\ malignancy\\ was\\ found\\ and\\ routine\\ annual\\ follow\\-up\\ was\\ recommended\\.\ \(0\)\
\-\ family\\ history\\ is\\ significant\\ for\\ breast\\ cancer\\ in\\:\\ sister\\ 39\\ years\\,\\ mother\\ 70\\ years\\,\\ paternal\\ aunt\\ 60\\ years\\.\ \(0\)\
\-\ the\\ most\\ common\\ type\\ of\\ breast\\ cancer\\ is\\ invasive\\ ductal\\ \\(70\\-80\\%\\)\\.\\ \\ invasive\\ ductal\\ carcinoma\\ typically\\ invades\\ in\\ a\\ fashion\\ creating\\ irregular\\,\\ stellate\\ shapes\\.\\ \\ a\\ fibrous\\ response\\ is\\ induced\\ by\\ the\\ malignant\\ cells\\;\\ leading\\ to\\ a\\ palpable\\ mass\\,\\ density\\ on\\ mammography\\ and\\ hypoechoic\\,\\ shadowing\\ nature\\ on\\ sonogram\\.\\ \\ \ \(0\)\
\-\ though\\ only\\ 15\\%\\ of\\ all\\ breast\\ cancers\\ have\\ a\\ genetic\\ factor\\ involved\\,\\ this\\ patient\\ has\\ a\\ history\\ of\\ two\\ first\\ degree\\ relatives\\ with\\ breast\\ cancer\\.\\ \\ annual\\ mammograms\\ would\\ likely\\ have\\ lead\\ to\\ an\\ earlier\\ diagnosis\\ and\\ treatment\\.\ \(0\)\
\-\ breast\\ imaging\\ reporting\\ and\\ data\\ system\ \(0\)\
\-\ birads\\:\ \(0\)\
\-\ 1\\ negative\\:\\ no\\ findings\\,\\ routine\\ follow\\ up\ \(1\)\
\-\ 2\\ benign\\:\\ all\\ findings\\ suggest\\ benign\\ pathology\\,\\ routine\\ follow\\-up\ \(1\)\
\-\ 3\\ probably\\ benign\\:\\ most\\ findings\\ suggest\\ benign\\ path\\,\\ less\\ than\\ 2\\ percent\\ probability\\ of\\ malignancy\\.\\ \\ short\\ interval\\ follow\\ up\\ is\\ recommended\ \(0\)\
\-\ 4\\ suspicious\\ findings\\:\\ consider\\ biopsy\\,\\ 2\\-75\\%\\ of\\ lesions\\ are\\ malignant\ \(1\)\
\-\ 5\\ highly\\ suggestive\\ of\\ malignancy\\:\\ \\ recommend\\ appropriate\\ management\\;\\ \\>75\\%\\ of\\ lesions\\ of\\ this\\ category\\ are\\ malignant\ \(1\)\
\-\ 0\\ incomplete\\.\\ \\ further\\ imaging\\ is\\ needed\\ to\\ evaluate\\ the\\ tissue\\.\ \(0\)\
\-\ many\\ critics\\ of\\ the\\ birads\\ system\\ suggest\\ only\\ 4\\ classifications\\ are\\ needed\\:\\ biopsy\\ recommended\\,\\ short\\ interval\\ followup\\ necessary\\,\\ benign\\ findings\\,\\ and\\ incomplete\\ study\\.\\ \ \(0\)\
\-\ commonly\\ used\\ indications\\ of\\ malignancy\\ on\\ sonogram\\:\\ \\ \ \(0\)\
\-\ 1\\.\\	spiculation\\,\\ \ \(1\)\
\-\ 2\\.\\	angular\\ margins\\,\\ \ \(1\)\
\-\ 3\\.\\	marked\\ hypoechogenecity\\,\\ \ \(1\)\
\-\ 4\\.\\	shadowing\\,\\ \ \(1\)\
\-\ 5\\.\\	duct\\ extension\\,\\ \ \(1\)\
\-\ 6\\.\\	branch\\ pattern\\,\\ \ \(1\)\
\-\ 7\\.\\	microlobulation\\.\\ \ \(1\)\
\-\ 8\\.\\	architectural\\ distortion\\,\\ \ \(0\)\
\-\ 9\\.\\	taller\\ than\\ wide\\,\\ \ \(1\)\
\-\ 10\\.\\	skin\\ thickening\\,\\ \ \(1\)\
\-\ 11\\.\\	marked\\ vascularity\\ \ \(1\)\
\-\ references\\:\ \(0\)\
\-\ crystal\\,\\ pavel\\,\\ selwyn\\ d\\.\\ strano\\,\\ semyon\\ shcharynski\\ and\\ michael\\ j\\.\\ koretz\\.\\ \\ using\\ sonography\\ to\\ screen\\ women\\ with\\ mammographically\\ dense\\ breasts\\.\\ ajr\\ \\ \\ \\ \\ \\ \\ \\ \\ 2003\\;\\ 181\\:177\\-182\\.\ \(0\)\
\-\ taplin\\,\\ stephen\\ h\\.\\,\\ carolyn\\ m\\.\\ rutter\\,\\ charles\\ finder\\,\\ margaret\\ t\\.\\ mandelson\\,\\ florence\\ houn\\ and\\ emily\\ white\\.\\ \\ screening\\ mammography\\ clinical\\ image\\ quality\\ and\\ the\ \(0\)\
\-\ risk\\ of\\ interval\\ breast\\ cancer\\.\\ \\ ajr\\ 2002\\;\\ 178\\:797\\-803\\.\ \(0\)\
\-\ esserman\\,\\ laura\\ j\\.\\ md\\,\\ mba\\.\\ \\ and\\ paul\\ c\\ stomper\\,\\ m\\.d\\.\\ diagnostic\\ evaluation\\ and\\ initial\\ staging\\ work\\-up\\ of\\ women\\ with\\ suspected\\ breast\\ cancer\\.\\ \\ \\ up\\-to\\-date\\.\\ \\ \\ \\ \\ 10\\ feb\\ 2005\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.28622044332025776\ \(0\)\
\-\ invasive\\:\\ 0\\.17932876890054494\ \(0\)\
\-\ benign\\:\\ 0\\.16245275170750872\ \(0\)\
\-\ birads\\:\\ 0\\.16036326774822596\ \(0\)\
\-\ 2002\\:\\ 0\\.1508774302793019\ \(0\)\
\-\ ductal\\:\\ 0\\.13874186861121682\ \(0\)\
\-\ cancer\\:\\ 0\\.1312659519447312\ \(0\)\
\-\ of\\:\\ 0\\.13112686496007603\ \(0\)\
\-\ density\\:\\ 0\\.13068108451500146\ \(0\)\
\-\ and\\:\\ 0\\.13031410195051643\ \(0\)\
\-\ mammography\\:\\ 0\\.12322210484469164\ \(0\)\
\-\ malignancy\\:\\ 0\\.11802993610971677\ \(0\)\
\-\ up\\:\\ 0\\.11698275173969887\ \(0\)\
\-\ findings\\:\\ 0\\.11671736053822827\ \(0\)\
\-\ shadowing\\:\\ 0\\.11397107407569573\ \(0\)\
\-\ mammogram\\:\\ 0\\.11289400700213253\ \(0\)\
\-\ the\\:\\ 0\\.11010614613443956\ \(0\)\
\-\ interval\\:\\ 0\\.10699638223368799\ \(0\)\
\-\ suggest\\:\\ 0\\.09605519967143895\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09430513435033609\ \(0\)\
\-\ recommended\\:\\ 0\\.09405836389565157\ \(0\)\
\-\ sonogram\\:\\ 0\\.0935721492563742\ \(0\)\
\-\ routine\\:\\ 0\\.09156990270908305\ \(0\)\
\-\ ajr\\:\\ 0\\.0881900375775426\ \(0\)\
\-\ follow\\:\\ 0\\.08499247428695741\ \(0\)\
\-\ malignant\\:\\ 0\\.08428929309979075\ \(0\)\
\-\ nipple\\:\\ 0\\.08335050202448363\ \(0\)\
\-\ palpable\\:\\ 0\\.08307148181500533\ \(0\)\
\-\ biopsy\\:\\ 0\\.08288557135181059\ \(0\)\
\-\ incomplete\\:\\ 0\\.07733473198499063\ \(0\)\
\-\ spot\\:\\ 0\\.076934145913898\ \(0\)\
\-\ mass\\:\\ 0\\.07527742765339282\ \(0\)\
\-\ 2001\\:\\ 0\\.07441459841212396\ \(0\)\
\-\ ultrasound\\:\\ 0\\.07293574819806417\ \(0\)\
\-\ annual\\:\\ 0\\.07286023683727427\ \(0\)\
\-\ years\\:\\ 0\\.07248263993447868\ \(0\)\
\-\ women\\:\\ 0\\.07094162104691576\ \(0\)\
\-\ appropriate\\:\\ 0\\.06925719496560707\ \(0\)\
\-\ 75\\:\\ 0\\.06914438412036869\ \(0\)\
\-\ to\\:\\ 0\\.06897574342238459\ \(0\)\
\-\ been\\:\\ 0\\.06889091161550548\ \(0\)\
\-\ in\\:\\ 0\\.06863624495611328\ \(0\)\
\-\ short\\:\\ 0\\.06775595656286551\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.06735537049177287\ \(0\)\
\-\ margins\\:\\ 0\\.06725701241250162\ \(0\)\
\-\ 70\\:\\ 0\\.06508482525458724\ \(0\)\
\-\ needed\\:\\ 0\\.06508482525458724\ \(0\)\
\-\ is\\:\\ 0\\.06476442643718996\ \(0\)\
\-\ 1200\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ assays\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ vies\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ mgmc\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ critics\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ hypoechogenecity\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ microlobulation\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ pavel\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ selwyn\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ strano\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ semyon\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ shcharynski\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ koretz\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ taplin\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ carolyn\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ rutter\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ finder\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ margaret\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ mandelson\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ florence\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ houn\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ emily\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ mba\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ stomper\\:\\ 0\\.0630331980048671\ \(0\)\
\-\ located\\:\\ 0\\.062357465538985773\ \(0\)\
\-\ irregular\\:\\ 0\\.060860271992646375\ \(0\)\
\-\ esserman\\:\\ 0\\.06023158579248079\ \(0\)\
\-\ laura\\:\\ 0\\.06023158579248079\ \(0\)\
\-\ system\\:\\ 0\\.06013910392924672\ \(0\)\
\-\ marked\\:\\ 0\\.059621899007435745\ \(0\)\
\-\ have\\:\\ 0\\.059069893725453765\ \(0\)\
\-\ phylloides\\:\\ 0\\.05824381029380455\ \(0\)\
\-\ taller\\:\\ 0\\.05824381029380455\ \(0\)\
\-\ studies\\:\\ 0\\.057826037883747024\ \(0\)\
\-\ view\\:\\ 0\\.05772732852263945\ \(0\)\
\-\ compression\\:\\ 0\\.05772732852263945\ \(0\)\
\-\ mammographically\\:\\ 0\\.056701971832305235\ \(0\)\
\-\ paul\\:\\ 0\\.056701971832305235\ \(0\)\
\-\ would\\:\\ 0\\.05580233916849839\ \(0\)\
\-\ relatives\\:\\ 0\\.055442198081418224\ \(0\)\
\-\ spiculation\\:\\ 0\\.055442198081418224\ \(0\)\
\-\ michael\\:\\ 0\\.055442198081418224\ \(0\)\
\-\ shapes\\:\\ 0\\.05437707455163599\ \(0\)\
\-\ stephen\\:\\ 0\\.05437707455163599\ \(0\)\
\-\ this\\:\\ 0\\.0541748430143564\ \(0\)\
\-\ with\\:\\ 0\\.054025676036147476\ \(0\)\
\-\ mediolateral\\:\\ 0\\.053454422582741995\ \(0\)\
\-\ menopausal\\:\\ 0\\.053454422582741995\ \(0\)\
\-\ paternal\\:\\ 0\\.053454422582741995\ \(0\)\
\-\ invades\\:\\ 0\\.053454422582741995\ \(0\)\
\-\ classifications\\:\\ 0\\.05264058586903189\ \(0\)\
\-\ angular\\:\\ 0\\.05264058586903189\ \(0\)\
\-\ reporting\\:\\ 0\\.05191258412124268\ \(0\)\
\-\ assymetric\\:\\ 0\\.05125402643436694\ \(0\)\
\-\ stellate\\:\\ 0\\.05065281037035566\ \(0\)\
\-\ receptor\\:\\ 0\\.05009974520433692\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.05009974520433692\ \(0\)\
\-\ her\\:\\ 0\\.04924853744543726\ \(0\)\
\-\ only\\:\\ 0\\.04924853744543726\ \(0\)\
\-\ aunt\\:\\ 0\\.04911097190885635\ \(0\)\
\-\ probability\\:\\ 0\\.04785119815796933\ \(0\)\
\-\ for\\:\\ 0\\.047785560522714016\ \(0\)\
\-\ sister\\:\\ 0\\.04747761388555842\ \(0\)\
\-\ all\\:\\ 0\\.0469256449696357\ \(0\)\
\-\ creating\\:\\ 0\\.0467860746281871\ \(0\)\
\-\ time\\:\\ 0\\.04672455287449707\ \(0\)\
\-\ crystal\\:\\ 0\\.04646463872330438\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.0461574936733601\ \(0\)\
\-\ 10\\:\\ 0\\.04609580395998156\ \(0\)\
\-\ recommend\\:\\ 0\\.0458634226592931\ \(0\)\
\-\ architectural\\:\\ 0\\.0458634226592931\ \(0\)\
\-\ quality\\:\\ 0\\.0458634226592931\ \(0\)\
\-\ fashion\\:\\ 0\\.045581357948680803\ \(0\)\
\-\ indications\\:\\ 0\\.045581357948680803\ \(0\)\
\-\ category\\:\\ 0\\.04531035749327436\ \(0\)\
\-\ feb\\:\\ 0\\.04531035749327436\ \(0\)\
\-\ lesions\\:\\ 0\\.04527298644808479\ \(0\)\
\-\ history\\:\\ 0\\.04517645846325457\ \(0\)\
\-\ are\\:\\ 0\\.04486862276580517\ \(0\)\
\-\ than\\:\\ 0\\.044686508688249235\ \(0\)\
\-\ at\\:\\ 0\\.04466265635317675\ \(0\)\
\-\ mammograms\\:\\ 0\\.0440950187887713\ \(0\)\
\-\ path\\:\\ 0\\.04366302651091805\ \(0\)\
\-\ august\\:\\ 0\\.043061810446906774\ \(0\)\
\-\ breasts\\:\\ 0\\.043061810446906774\ \(0\)\
\-\ spiculated\\:\\ 0\\.04268822617449586\ \(0\)\
\-\ cancers\\:\\ 0\\.042333808699117556\ \(0\)\
\-\ sonography\\:\\ 0\\.041834099982787545\ \(0\)\
\-\ distortion\\:\\ 0\\.041675251012241815\ \(0\)\
\-\ imaging\\:\\ 0\\.04142785404004404\ \(0\)\
\-\ most\\:\\ 0\\.04102554013051462\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.04093156338734231\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04086493423427815\ \(0\)\
\-\ screen\\:\\ 0\\.04065514149117155\ \(0\)\
\-\ staging\\:\\ 0\\.04026019823452044\ \(0\)\
\-\ charles\\:\\ 0\\.0401334125507425\ \(0\)\
\-\ 5cm\\:\\ 0\\.04000891141844831\ \(0\)\
\-\ lobular\\:\\ 0\\.04000891141844831\ \(0\)\
\-\ exam\\:\\ 0\\.03968308178511373\ \(0\)\
\-\ acoustic\\:\\ 0\\.03953219648673122\ \(0\)\
\-\ vascularity\\:\\ 0\\.0394179851938661\ \(0\)\
\-\ induced\\:\\ 0\\.03908625944955431\ \(0\)\
\-\ hard\\:\\ 0\\.038979131320712485\ \(0\)\
\-\ percent\\:\\ 0\\.038979131320712485\ \(0\)\
\-\ genetic\\:\\ 0\\.03887363879985549\ \(0\)\
\-\ consider\\:\\ 0\\.03876973269294178\ \(0\)\
\-\ data\\:\\ 0\\.03866736599249532\ \(0\)\
\-\ branch\\:\\ 0\\.03866736599249532\ \(0\)\
\-\ patient\\:\\ 0\\.038459182195232255\ \(0\)\
\-\ probably\\:\\ 0\\.03827242273584421\ \(0\)\
\-\ irregularity\\:\\ 0\\.03817711603999648\ \(0\)\
\-\ wide\\:\\ 0\\.03817711603999648\ \(0\)\
\-\ treatment\\:\\ 0\\.037550931116234414\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.037544420988054994\ \(0\)\
\-\ 2005\\:\\ 0\\.037458586022134116\ \(0\)\
\-\ workup\\:\\ 0\\.037125527530996\ \(0\)\
\-\ factor\\:\\ 0\\.036964831313841325\ \(0\)\
\-\ 56\\:\\ 0\\.03680778760154221\ \(0\)\
\-\ response\\:\\ 0\\.03635700000193399\ \(0\)\
\-\ has\\:\\ 0\\.03600726555724322\ \(0\)\
\-\ earlier\\:\\ 0\\.03600258252655568\ \(0\)\
\-\ md\\:\\ 0\\.0359338294627826\ \(0\)\
\-\ on\\:\\ 0\\.03571203796225757\ \(0\)\
\-\ asymmetric\\:\\ 0\\.03547081052345788\ \(0\)\
\-\ 2003\\:\\ 0\\.03547081052345788\ \(0\)\
\-\ highly\\:\\ 0\\.035281493861783995\ \(0\)\
\-\ suspicious\\:\\ 0\\.03521952370738575\ \(0\)\
\-\ lead\\:\\ 0\\.03509722625104698\ \(0\)\
\-\ leading\\:\\ 0\\.035036879789735666\ \(0\)\
\-\ nature\\:\\ 0\\.03480063025032676\ \(0\)\
\-\ followup\\:\\ 0\\.03480063025032676\ \(0\)\
\-\ dense\\:\\ 0\\.03474280877566866\ \(0\)\
\-\ degree\\:\\ 0\\.034460744065056365\ \(0\)\
\-\ 29\\:\\ 0\\.03435106516061196\ \(0\)\
\-\ though\\:\\ 0\\.03424310005933866\ \(0\)\
\-\ that\\:\\ 0\\.03420928130074441\ \(0\)\
\-\ complaint\\:\\ 0\\.034136796025661456\ \(0\)\
\-\ included\\:\\ 0\\.03408425108879293\ \(0\)\
\-\ showing\\:\\ 0\\.03403210272126474\ \(0\)\
\-\ duct\\:\\ 0\\.033928972061958565\ \(0\)\
\-\ mother\\:\\ 0\\.033677685245886435\ \(0\)\
\-\ by\\:\\ 0\\.03347580710692723\ \(0\)\
\-\ necessary\\:\\ 0\\.03297440490514686\ \(0\)\
\-\ 39\\:\\ 0\\.03275503327699243\ \(0\)\
\-\ pending\\:\\ 0\\.03241791149499942\ \(0\)\
\-\ using\\:\\ 0\\.03241791149499942\ \(0\)\
\-\ suspected\\:\\ 0\\.032295614038660644\ \(0\)\
\-\ suggestive\\:\\ 0\\.0320964755901167\ \(0\)\
\-\ last\\:\\ 0\\.03205732746329959\ \(0\)\
\-\ screening\\:\\ 0\\.03201839989047965\ \(0\)\
\-\ compared\\:\\ 0\\.03186484632898068\ \(0\)\
\-\ as\\:\\ 0\\.03166882495188315\ \(0\)\
\-\ involved\\:\\ 0\\.03160407478128932\ \(0\)\
\-\ references\\:\\ 0\\.03142365654441211\ \(0\)\
\-\ from\\:\\ 0\\.03130795001530066\ \(0\)\
\-\ films\\:\\ 0\\.031213194815493117\ \(0\)\
\-\ views\\:\\ 0\\.031110320072996533\ \(0\)\
\-\ many\\:\\ 0\\.031076366069046426\ \(0\)\
\-\ family\\:\\ 0\\.03100895454996247\ \(0\)\
\-\ pathology\\:\\ 0\\.030942194360086675\ \(0\)\
\-\ evaluate\\:\\ 0\\.030649507624477615\ \(0\)\
\-\ fibrous\\:\\ 0\\.030617739173574247\ \(0\)\
\-\ cells\\:\\ 0\\.030368716695028407\ \(0\)\
\-\ currently\\:\\ 0\\.030277599428703096\ \(0\)\
\-\ an\\:\\ 0\\.03014434285202369\ \(0\)\
\-\ diagnostic\\:\\ 0\\.030040335743928614\ \(0\)\
\-\ reveals\\:\\ 0\\.029982271319044598\ \(0\)\
\-\ change\\:\\ 0\\.029867586098685228\ \(0\)\
\-\ midline\\:\\ 0\\.029643772980437876\ \(0\)\
\-\ used\\:\\ 0\\.02950748402742919\ \(0\)\
\-\ 60\\:\\ 0\\.029480545880639763\ \(0\)\
\-\ pattern\\:\\ 0\\.029426982620939204\ \(0\)\
\-\ skin\\:\\ 0\\.02932108589838566\ \(0\)\
\-\ commonly\\:\\ 0\\.029165223066397\ \(0\)\
\-\ management\\:\\ 0\\.029114040418293383\ \(0\)\
\-\ metastasis\\:\\ 0\\.028888297534823873\ \(0\)\
\-\ risk\\:\\ 0\\.028162763951340115\ \(0\)\
\-\ extension\\:\\ 0\\.027901169584249194\ \(0\)\
\-\ typically\\:\\ 0\\.02766977540437201\ \(0\)\
\-\ was\\:\\ 0\\.027473049546549437\ \(0\)\
\-\ new\\:\\ 0\\.02726793975223703\ \(0\)\
\-\ underwent\\:\\ 0\\.027151808852219777\ \(0\)\
\-\ less\\:\\ 0\\.026814687070226762\ \(0\)\
\-\ thickening\\:\\ 0\\.026814687070226762\ \(0\)\
\-\ size\\:\\ 0\\.02668790138644882\ \(0\)\
\-\ 15\\:\\ 0\\.026634268833349548\ \(0\)\
\-\ first\\:\\ 0\\.026598743686201038\ \(0\)\
\-\ type\\:\\ 0\\.026441102797815853\ \(0\)\
\-\ initial\\:\\ 0\\.026441102797815853\ \(0\)\
\-\ along\\:\\ 0\\.026406554596342093\ \(0\)\
\-\ study\\:\\ 0\\.02628697835798387\ \(0\)\
\-\ right\\:\\ 0\\.02613542006400467\ \(0\)\
\-\ white\\:\\ 0\\.026004913647371567\ \(0\)\
\-\ further\\:\\ 0\\.02567166388895965\ \(0\)\
\-\ past\\:\\ 0\\.02565618879648962\ \(0\)\
\-\ no\\:\\ 0\\.02563463216484121\ \(0\)\
\-\ superior\\:\\ 0\\.02562534220106405\ \(0\)\
\-\ differential\\:\\ 0\\.02560997039072046\ \(0\)\
\-\ found\\:\\ 0\\.02550331473108458\ \(0\)\
\-\ image\\:\\ 0\\.02520735403400303\ \(0\)\
\-\ approximately\\:\\ 0\\.025149653273640132\ \(0\)\
\-\ clinical\\:\\ 0\\.02497938693598098\ \(0\)\
\-\ negative\\:\\ 0\\.0244015695597541\ \(0\)\
\-\ evaluation\\:\\ 0\\.024037490522466533\ \(0\)\
\-\ following\\:\\ 0\\.023645265450704788\ \(0\)\
\-\ weeks\\:\\ 0\\.02362219489204423\ \(0\)\
\-\ region\\:\\ 0\\.023576283587584023\ \(0\)\
\-\ likely\\:\\ 0\\.023553441828271147\ \(0\)\
\-\ two\\:\\ 0\\.02340678303814682\ \(0\)\
\-\ however\\:\\ 0\\.023329083614891014\ \(0\)\
\-\ significant\\:\\ 0\\.022757364397808323\ \(0\)\
\-\ cm\\:\\ 0\\.022636493224042396\ \(0\)\
\-\ evidence\\:\\ 0\\.0223720245143496\ \(0\)\
\-\ common\\:\\ 0\\.022352831096731356\ \(0\)\
\-\ these\\:\\ 0\\.022257655681478312\ \(0\)\
\-\ prior\\:\\ 0\\.022052773056988988\ \(0\)\
\-\ more\\:\\ 0\\.021643061828390465\ \(0\)\
\-\ post\\:\\ 0\\.021446970450559287\ \(0\)\
\-\ physical\\:\\ 0\\.02137172877167468\ \(0\)\
\-\ increased\\:\\ 0\\.02131376871786275\ \(0\)\
\-\ tissue\\:\\ 0\\.020676231204215932\ \(0\)\
\-\ tumor\\:\\ 0\\.020616342414127256\ \(0\)\
\-\ posterior\\:\\ 0\\.020381846920777057\ \(0\)\
\-\ were\\:\\ 0\\.02031730401961652\ \(0\)\
\-\ present\\:\\ 0\\.02022512703773903\ \(0\)\
\-\ demonstrates\\:\\ 0\\.01980167755564483\ \(0\)\
\-\ case\\:\\ 0\\.01980167755564483\ \(0\)\
\-\ had\\:\\ 0\\.019638012255968205\ \(0\)\
\-\ well\\:\\ 0\\.019084947089949466\ \(0\)\
\-\ female\\:\\ 0\\.019019565195746244\ \(0\)\
\-\ presents\\:\\ 0\\.018960659247337485\ \(0\)\
\-\ images\\:\\ 0\\.018232070968764023\ \(0\)\
\-\ year\\:\\ 0\\.012146933216016759\ \(0\)\
\-\ old\\:\\ 0\\.011665260652656686\ \(0\)\
